Green dye vs standard surgery for pancreas tail tumors
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial compares standard laparoscopic surgery to surgery using a green dye that helps the surgeon see the pancreas more clearly. It may help patients needing removal of tumors in the body or tail of the pancreas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your body mass index (BMI) is 40 or less.
- You have a tumor in the body or tail of the pancreas that can be removed with laparoscopic (minimally invasive) surgery.
- You are in generally good health (able to do daily activities without significant limitation).
- Your liver and blood clotting function are within safe limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a green dye called indocyanine green (ICG) that is injected during pancreas surgery to see how well blood flows to the remaining tissue. The goal is to learn if this dye can help predict complications, such as leaks from the pancreas, after surgery.
This trial tests whether a green dye called indocyanine green can help surgeons find and remove more lymph nodes during laparoscopic surgery for advanced stomach cancer. It may improve the chances of removing all cancer.
This study tests whether using a green dye (called indocyanine green) during keyhole surgery helps doctors find and remove lymph nodes more accurately in stomach cancer. It may help reduce the chance of leaving cancer behind.
This trial tests whether a special dye (SGM-101) can help surgeons see remaining cancer cells during surgery for pancreatic cancer that has been treated before surgery. It may lead to more complete removal of the tumor.
This trial tests whether using a green dye (called indocyanine green) during minimally invasive surgery can help the surgeon see and remove lymph nodes more effectively for stomach cancer. The dye is injected near the tumor and may improve the accuracy of lymph node removal, which could help reduce the risk of cancer coming back.
This trial tests whether a special green dye (indocyanine green) injected during minimally invasive stomach cancer surgery helps doctors remove more lymph nodes, which may improve treatment. It is for people with stomach adenocarcinoma that has not spread to distant organs.
Hear when a new Pancreatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.